Barcelona 2022

Browse: Pre-Congress Content Sunday, 04.09.2022 Monday, 05.09.2022 Tuesday, 06.09.2022		Monday, 14.11.2022 Tuesday, 15.11.2022 Wednesday, 16.11.2022 Thursday, 17.11.2022 Friday, 18.11.2022

Citations should be made in the following way: Authors. Title. Eur Respir J 2022; 60: Suppl. 66, abstract number.

ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials

Statements and technical standards
Aims: to explain the burden and effect of pulmonary exacerbations in children and adolescents with bronchiectasis; to describe the importance of exacerbations in children and adolescents with bronchiectasis; to list the recommendations for defining severe and nonsevere exacerbations for clinical trials, and how these differ from those for clinical care.

ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials A. Chang (Brisbane (QLD), Australia)